Sanofi Pasteur builds major manufacturing facility for vaccines

10/5/2011 | Business Standard (India)

Sanofi's vaccine division, Sanofi Pasteur, is building a state-of-the-art plant in India as part of a 2015 goal to achieve 40% of sales from emerging markets. The facility, touted as the largest in Asia, will be fully operational in October 2012. Sanofi invested $300 million for capacity expansion after buying India's Shantha Biotechnics in 2009, said CEO Chris Viehbacher.

View Full Article in:

Business Standard (India)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA